| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/28/2026 | ±3.5% | -3.7% | under-priced |
| 05/29/2026 | ±3.6% | -4.0% | under-priced |
| 03/03/2026 | ±3.9% | +2.6% | over-priced |
| 11/26/2025 | ±2.4% | +2.4% | over-priced |
| 09/02/2025 | ±4.0% | +1.4% | over-priced |
| 05/29/2025 | ±2.3% | -0.8% | over-priced |
| 03/06/2025 | ±4.0% | -2.6% | over-priced |
| 12/03/2024 | ±3.4% | +0.8% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2027 | $2.33 | $2.0B | $492M |
| Q1 FY2027 | $2.32 | $1.9B | $491M |
| Q4 FY2026 | — | $2.0B | $316M |
| Q3 FY2026 | $1.60 | $1.9B | $343M |
ADSK (ADSK) reports in 30 days, with the next report estimated for 11/26/2026. Across the last 8 reports, options priced an average ±3.4% earnings move while the stock actually moved 2.3% on average — the market has systematically over-priced ADSK's earnings risk. Fundamentals into the print: EPS up 59.6% year-over-year, revenue up 16.1%. QuantLogix's live 5-factor engine currently reads ADSK as a buy at 71/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →